Related references
Note: Only part of the references are listed.Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
Andrea Rinaldi et al.
BLOOD (2011)
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group
Marta Salido et al.
BLOOD (2010)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy
Neil E. Kay et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications
Wee J. Chng et al.
BLOOD (2009)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia
Esteban Braggio et al.
CANCER RESEARCH (2009)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Roland Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands
E. Chanudet et al.
JOURNAL OF PATHOLOGY (2009)
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)
I. Nagel et al.
LEUKEMIA (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
High-Resolution Genomic Analysis in Waldenstrom's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas
Esteban Braggio et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma
Keiichiro Honma et al.
GENES CHROMOSOMES & CANCER (2008)
Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia
Bibiana Ferreira et al.
HAEMATOLOGICA (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multifunctional roles for MALT1 in T-cell activation
Margot Thome
NATURE REVIEWS IMMUNOLOGY (2008)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations
Cristina Largo et al.
HAEMATOLOGICA (2007)
Waldenstrom macroglobulinaemia
Rafael Fonseca et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21)
YP Zhou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Efficient calculation of interval scores for DNA copy number data analysis
D Lipson et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2006)
Trisomy 4, a new chromosomal abnormality in Waldenstrom's macroglobulinemia: a study of 39 cases
C. Terre et al.
LEUKEMIA (2006)
Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma
P Farinha et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Timeline - MALT lymphoma: from morphology to molecules
PG Isaacson et al.
NATURE REVIEWS CANCER (2004)
A20 is a potent inhibitor of TLR3-and Sendai virus-induced activation of NF-κB and ISRE and IFN-β promoter
YY Wang et al.
FEBS LETTERS (2004)
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
DL Boone et al.
NATURE IMMUNOLOGY (2004)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Developing diagnostic criteria in Waldenstrom's macroglobulinemia
RG Owen
SEMINARS IN ONCOLOGY (2003)
T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma
B Streubel et al.
BLOOD (2003)
Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
RFJ Schop et al.
BLOOD (2002)
Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways
P Starostik et al.
BLOOD (2002)
Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-κB signaling pathway
PC Lucas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
